Geron Corporation To Discontinue Phase 3 IMpactMF Clinical Trial Of Imetelstat In Relapsed/Refractory Myelofibrosis
Share
Why It Matters
Geron stopped testing a medicine called imetelstat in patients. This tells you the drug may not be working as well as hoped.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.